Health tech accelerator welcomes AltPAP Innovation to its new state-of-the-art facility
The Clinical Innovation Platform (CLIP) of the Research Institute of the McGill University Health Centre (RI-MUHC) is pleased to announce the residency of its first member company, AltPAP Innovation. In brand new facilities designed to help healthcare start-up companies, the CLIP will provide access to research space, mentorship, clinical trial services and tools for the development of innovative new products.
AltPAP Innovation is a leading-edge Canadian start-up company. Focused on emergency solutions for respiratory assistance during COVID-19, AltPAP’s mission is to support development of emergent, non-invasive oxygenation therapies and to facilitate the adoption of these therapies in Canadian hospitals. Simulation tests and design optimization for new oxygenation devices are a key part of AltPAP innovation’s expertise, as is the creation of resources for respiratory therapists.
“We are very excited by the possibilities for collaboration and innovation at the CLIP,” says AltPAP Innovation director Michael Sendbuehler. “It is a fantastic new facility, ideally located in the heart of the Montreal General Hospital.”
“Our non-profit organization is committed to accelerating innovation in respiratory technology to better fight COVID-19 now, and also to increasing and sustaining the availability of proper respiratory therapies in lower-middle-income areas,” says Sébastien Proulx, a cofounder of AltPAP Innovation and PhD candidate at McGill University. “We do so by enabling innovators from all horizons with equipment and expertise and by uniting scientific, industrial and clinical efforts through open science principles. The CLIP is the perfect place to make all that happen.”
Additional members of the AltPAP Innovation team include Tatiana Ruiz, M.Sc, respiratory therapists Patricia McClurg, RRT, and Marco Zaccagnini, RRT. Collaborator Reza Farivar, PhD, is leader of the CodeLife ventilator challenge.
“We are proud to offer concrete support to this young company and to the fight against COVID-19,” says Jake Barralet, PhD, scientific director of the CLIP. “In turn, we warmly acknowledge MEDTEQ’s support allowing us to contribute to the National Beachhead medical technology initiative. As well, the Montreal General Hospital Foundation and the generous support of our patients and donors made the CLIP possible.”
About the CLIP
The Clinical Innovation Platform (CLIP), powered by National Bank, at the Research Institute of the McGill University Health Centre is a state-of-the-art facility within the Montreal General Hospital of the MUHC (MGH), designed to help health tech start-ups develop and grow. In addition to newly renovated research and meeting space, the CLIP provides access to mentorship from strategic industry experts and key opinion leaders, pre-clinical and clinical trial services, rapid prototyping, and laboratories for product development. The CLIP acts as a nexus point for teams developing new products, facilitating assessment of new technologies within a hospital setting. Apply for membership at the CLIP or visit ClinicalInnovation.ca.
AltPAP Innovation ensures the support of emergent non-invasive respiratory therapies and facilitates their adoption in Canadian hospitals. A non-profit organization, AltPAP is committed to bringing respiratory therapies to underserved populations by promoting open scientific communication, supporting research, coordinating collaboration, providing expertise, and connecting industry with healthcare. Visit: AltPAP.com
The MEDTEQ Beachhead™ Network is a partnership between centers of clinical excellence and companies to accelerate the adoption of value-based innovations. The Beachhead™ centers form a network that shares evaluation processes, best certified technologies and best training practices to improve technology implementation.
About the Montreal General Hospital Foundation
Since 1973, the Montreal General Hospital Foundation (MGHF) has played a key role within the Montreal General Hospital (MGH) and the McGill University Health Network as a proud sponsor of significant medical R&D and technology development and acquisition. The MGHF now manages the third largest healthcare fund in Quebec, with $170 million in assets. In accordance with the wishes of donors, the funds raised by the MGHF go toward supporting patient care, research programs, acquiring cutting-edge equipment, and helping medical teams with their priority needs. Its leadership and strong relationships with the healthcare community have made the MGHF a sound advisor for donors as to where funds are most needed and can have the greatest impact. Visit: www.codelife.ca
January 12, 2021